ME Therapeutics Holdings Inc. (CSE:METX)
1.050
0.00 (0.00%)
Nov 19, 2026, 9:30 AM EST
ME Therapeutics Holdings Market Cap
ME Therapeutics Holdings has a market cap or net worth of CAD 31.91 million as of November 20, 2026. It is the 35,531st most valuable company in the world and the 1,040th biggest in Canada. Its market cap has decreased by 73.04% in one year.
Market Cap
31.91M
Enterprise Value
31.40M
Revenue
n/a
Global Rank
Country Rank
#1,040 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since October 12, 2023, ME Therapeutics Holdings's market cap has increased from 14.43M to 31.91M, an increase of 121.10%. That is a compound annual growth rate of 29.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 31.91M | -73.45% |
| Dec 17, 2025 | 120.20M | 19.29% |
| Dec 30, 2024 | 100.76M | 256.37% |
| Dec 29, 2023 | 28.27M | 95.92% |
| Oct 12, 2023 | 14.43M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sharp Therapeutics | 43.26M |
| BriaCell Therapeutics | 43.23M |
| NurExone Biologic | 42.90M |
| Thiogenesis Therapeutics | 41.99M |
| Microbix Biosystems | 40.41M |
| Sernova Biotherapeutics | 37.76M |
| MedMira | 35.09M |
| Sona Nanotech | 30.70M |